← Transmissions
PHARMACOLOGY

What Is DMT? The Complete Guide to the Most Mysterious Molecule in Nature

June 6, 2026·6 min read

DMT — dimethyltryptamine — is a molecule produced by hundreds of plants, by the human brain, and by the pineal gland of mammals. It produces what researchers describe as the most intense altered state of consciousness known to science — in approximately 15 minutes.

It was first synthesized in the lab in 1931. We still don't fully understand why it exists.

1931
Year DMT was first synthesized — by Canadian chemist Richard Manske
400+
Plant species known to contain DMT
5
Sites in the human body confirmed to produce endogenous DMT
15
Minutes duration of inhaled DMT experience — yet rated among the most meaningful of people's lives

What DMT is chemically

DMT belongs to the tryptamine family — the same chemical class as serotonin, psilocybin, and melatonin. Its full name is N,N-dimethyltryptamine. The molecule is structurally simple: a tryptamine backbone with two methyl groups attached to the amine.

A first-year chemistry student could draw it from memory. It is smaller and less complex than aspirin. The contrast between its molecular simplicity and the profundity of its effects is one of the most striking things about it.

Where DMT is found

DMT is not rare. It appears in hundreds of unrelated plant species across every continent, in trace amounts in a wide range of animals, and in the human body itself.

The distribution is striking. Psilocybin evolved independently at least four times in fungi — already a remarkable pattern. DMT appears in plants, animals, and mammalian nervous systems simultaneously. That is not the signature of a single evolutionary event. It is the signature of something widely distributed.

PropertyDMTPsilocybinLSD
Duration15 min inhaled / 4-8h oral (ayahuasca)4-6 hours8-12 hours
IntensityHighest knownHighHigh
EndogenousYes — in human brainNoNo
Plant sources400+ species200+ fungiErgot fungi
Primary receptor5-HT2A + sigma-15-HT2A5-HT2A
Entity encountersVery common ~60%DocumentedLess common
Oral activityRequires MAOIYesYes

How DMT works in the brain

DMT primarily activates the 5-HT2A serotonin receptor — the same receptor targeted by psilocybin and LSD. But DMT also has high affinity for sigma-1 receptors, which regulate neuroplasticity, neuroprotection, and stress response. This dual binding profile may explain some of what makes the DMT experience distinct.

The speed of onset when inhaled — full effect in under a minute — is unlike any other psychedelic. The brain changes happen faster than the mechanism for gradual altered states. This may be why the DMT experience feels less like a drug effect and more like being transported.

The DMT experience

The characteristic phenomenology of inhaled DMT is unlike other psychedelics. Onset is near-instantaneous. The visual field is replaced by intensely geometric imagery that rapidly gives way to what most users describe as a different space or dimension.

Entity encounters occur in roughly 60% of intense DMT experiences — more commonly than with any other compound. The entities are described as intelligent, purposeful, and aware of the human's presence. The experience ends as rapidly as it begins. Return to baseline is essentially complete within 20-30 minutes.

Why DMT is orally inactive without MAOIs

Orally consumed DMT is destroyed by monoamine oxidase enzymes in the gut before it reaches the brain. This is why DMT taken alone by mouth produces no significant effect.

Ayahuasca is the indigenous solution to this problem: combining DMT-containing plants with plants rich in MAO inhibitors. This combination — discovered thousands of years ago in the Amazon — allows oral activity. The pharmacological sophistication required to identify this combination is remarkable.

The endogenous question

DMT is produced in the human body. It has been confirmed in human brain tissue, blood, urine, and cerebrospinal fluid. The enzyme that synthesizes it — INMT — is expressed throughout the body, including heavily in the lungs and thyroid.

What the body uses it for naturally remains unresolved. Rick Strassman, who ran the first controlled human DMT studies, proposed it is released by the pineal gland during extreme physiological states — deep sleep, birth, death, and near-death experiences. The hypothesis is not confirmed, but the dream and DMT connection is one of the most intriguing open questions in neuroscience.

The near-death connection

The phenomenological overlap between intense DMT experiences and near-death experiences is extensive. Both involve the sense of leaving the body, entering a non-ordinary space, encountering presences, receiving information, and returning transformed. Both are described as more real than ordinary waking life.

If endogenous DMT is active during dying — a hypothesis that cannot currently be tested directly — it would provide a neurochemical account of what NDEs are. It would also connect the most extreme natural human experience to the most extreme induced one through the same molecule.

The entity encounter problem

The entity encounter data is the most scientifically uncomfortable feature of DMT research. In the Johns Hopkins entity encounter survey, 96% of respondents believed the entities they encountered were conscious and intelligent. 80% believed the entities continued to exist after the experience ended.

The Simplicity Paradox

DMT has 4 atoms of nitrogen and 12 of carbon. Aspirin is more chemically complex. Yet DMT produces experiences of contact with what feels like vast non-human intelligence — experiences rated by most people who have them as among the most real and meaningful of their lives. The simplicity of the molecule and the profundity of its effects are in startling contrast.

Cross-cultural consistency makes this harder to dismiss. The machine elves described by Western DMT users, the spirits of ayahuasca traditions, the figures encountered in near-death experiences — the phenomenological family resemblance across settings with no cultural contact is not what you predict from individual brain hallucinations.

The Technospermia interpretation

The Technospermia Question

If you were designing a consciousness interface molecule — one that would work across species, be producible by the body itself, and reliably produce contact with the intelligence behind the technology — you would design something that looks exactly like DMT. Simple. Universal. Pre-installed.

A molecule found in hundreds of unrelated organisms, produced by the human brain itself, that produces the most intense consciousness experience known — and consistently produces encounters with what feels like non-human intelligence.

DMT is a molecule so simple that a first-year chemistry student could draw it. It is found in the human brain, in hundreds of plants, and in the tissue of mammals across species. It produces the most intense experience of consciousness available. And it consistently produces encounters with what 96% of people who experience it describe as conscious, intelligent, non-human beings. For a molecule this simple, that is an extraordinary profile.

If this is random evolution, it is the most improbable random evolution in biology. The same molecule, from unrelated origins, producing the same experience, consistent across all of human history. The Technospermia framework proposes a simpler explanation: it was designed to.

Read more about DMT in your brain, DMT entity encounters, ayahuasca, NDEs and psilocybin, or the core theory.

Share this transmission